HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minoru Gotoh Selected Research

Seasonal Allergic Rhinitis (Hay Fever)

11/2021Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets.
8/2021Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis.
3/2020Association of Basophil-Expressing Genes with Effectiveness of Sublingual Immunotherapy.
1/2020Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet.
10/2019Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons.
9/2018Microarray-Based Multivariate Analysis of the Effectiveness of Sublingual Immunotherapy for Cedar Pollinosis.
1/2018Serum Cytokine Interactions Are Implicated in the Mechanism of Action of Sublingual Immunotherapy for Japanese Cedar Pollinosis.
1/2018[INVESTIGATION OF TREATMENT GOAL IN ALLERGEN IMMUNOTHERAPY FOR JAPANESE CEDAR POLLINOSIS].
11/2012Noninvasive biological evaluation of response to pranlukast treatment in pediatric patients with Japanese cedar pollinosis.
1/2012The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Minoru Gotoh Research Topics

Disease

20Seasonal Allergic Rhinitis (Hay Fever)
11/2021 - 06/2004
12Allergic Rhinitis
01/2022 - 02/2005
3Hypersensitivity (Allergy)
10/2019 - 02/2005
3Perennial Allergic Rhinitis
06/2017 - 12/2010
3Sneezing
12/2011 - 09/2006
2Anaphylaxis (Anaphylactic Shock)
02/2014 - 06/2009
2Asthma (Bronchial Asthma)
11/2012 - 01/2012
2Nasal Obstruction
11/2012 - 01/2012
1Drug-Related Side Effects and Adverse Reactions
01/2020
1Rhinitis
10/2019
1Conjunctivitis
10/2019
1Fatigue
12/2013
1Rhinorrhea
12/2011
1Eosinophilia
12/2008

Drug/Important Bio-Agent (IBA)

5AntigensIBA
02/2014 - 09/2006
4Pharmaceutical PreparationsIBA
08/2021 - 06/2004
4pranlukastIBA
11/2012 - 12/2011
3TabletsIBA
11/2021 - 10/2019
3AllergensIBA
03/2020 - 06/2009
3Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
01/2012 - 12/2011
2Immunoglobulin E (IgE)IBA
01/2020 - 09/2009
2Anti-Allergic Agents (Antiallergic Agents)IBA
09/2018 - 06/2004
2bilastineIBA
06/2017 - 01/2017
2epinastineFDA Link
03/2011 - 09/2006
2fexofenadine (Allegra)FDA LinkGeneric
09/2006 - 02/2005
1Immunoglobulin G (IgG)IBA
01/2020
1Messenger RNA (mRNA)IBA
09/2018
1Therapeutic UsesIBA
01/2018
1CytokinesIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2017
1Oxygen (Dioxygen)IBA
12/2013
1Lactalbumin (alpha-Lactalbumin)IBA
12/2013
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2013
1Biological ProductsIBA
11/2012
1leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
11/2012
1Eosinophil Cationic ProteinIBA
11/2012
1montelukast (Singulair)FDA Link
01/2012
1Dust (House Dust)FDA Link
12/2010
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2010
1bepotastineFDA Link
03/2009
1Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA
09/2006
1Histamine Antagonists (Antihistamines)IBA
02/2005
1Ophthalmic Solutions (Eye Drops)IBA
06/2004
1SteroidsIBA
06/2004

Therapy/Procedure

3Immunotherapy
01/2022 - 06/2009
3Oral Administration
01/2012 - 12/2008
1Drug Therapy (Chemotherapy)
06/2009